PUBLIC LAW 106-172—FEB. 18, 2000 114 STAT. 9 hydroxybutyric acid (together with its salts, isomers, and salts of isomers) is deemed to be scheduled under section 202(c) of the Controlled Substances Act in accordance with the policies described in paragraph (1), as if the Attorney General had issued a final order in accordance with such paragraph. (b) ADDITIONAL PENALTIES RELATING TO GHB. — (1) CONTROLLED SUBSTANCES ACT.— (A) IN GENERAL.—Section 401(b)(1)(C) of the Controlled Substances Act (21 U.S.C. 841(b)(1)(C)) is amended in the first sentence by inserting after "schedule I or II," the following: "gamma hydroxybutyric acid (including when scheduled as an approved drug product for purposes of section 3(a)(1)(B) of the Hillory J. Farias and Samantha Reid Date-Rape Drug Prohibition Act of 2000),". (B) CONFORMING AMENDMENT. —Section 401(b)(1)(D) of the Controlled Substances Act (21 U.S.C. 841(b)(1)(D)) is amended by striking ", or 30" and inserting "(other than gamma hydroxybutyric acid), or 30". (2) CONTROLLED SUBSTANCES IMPORT AND EXPORT ACT.— (A) IN GENERAL.—Section 1010(b)(3) of the Controlled Substances Import and Export Act (21 U.S.C. 960(b)(3)) is amended in the first sentence by inserting after "I or II," the following: "gamma hydroxybutyric acid (including when scheduled as an approved drug product for purposes of section 3(a)(1)(B) of the Hillory J. Farias and Samantha Reid Date-Rape Drug Prohibition Act of 2000),". (B) CONFORMING AMENDMENT.—{Section 1010(b)(4) of the Controlled Substances Import and Export Act (21 U.S.C. 960(b)(4)) is amended by striking "flunitrazepam)" and inserting the following: "flunitrazepam and except a violation involving gamma hydroxybutyric acid)". (c) GAMMA BUTYROLACTONE AS ADDITIONAL LIST I CHEMICAL.— Section 102(34) of the Controlled Substances Act (21 U.S.C. 802(34)) is amended— (1) by redesignating subparagraph (X) as subparagraph (Y); and (2) by inserting after subparagraph (W) the following subparagraph: "(X) Gamma butyrolactone.". SEC. 4. AUTHOMTY FOR ADDITIONAL REPORTING REQUIREMENTS FOR GAMMA HYDROXYBUTYRIC PRODUCTS IN SCHEDULE III. Section 307 of the Controlled Substances Act (21 U.S.C. 827) is amended by adding at the end the following: "(h) In the case of a drug product containing gamma hydroxy- butjn^ic acid for which an application has b»een approved under section 505 of the Federal Food, Drug, an(d Cosmetic Act, the Attorney General may, in addition to any other requirements that apply under this section with respect to such a drug product, establish any of the following as reporting requirements: "(1) That every person who is registered as a manufacturer of bulk or dosage form, as a packager, repackager, labeler, relabeler, or distributor shall report acquisition and distribution transactions quarterly, not later than the ]L5th day of the month succeeding the quarter for which the report is submitted, and annually report end-of-year inventories. Records. Deadline.
�
